PROVIDER PROFILE · NPI 1962448845

Margerie BurnessM.D.

OphthalmologySarasota, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

722

Unique beneficiaries

—

Total services

877

Distinct HCPCS

Medicare payment

$79K

Peer benchmark

Total Medicare services vs. 1,263 Ophthalmology providers in FL — below median (cohort median 2,598).

PRESCRIBING · PART D · 2024

Total Rx claims

538

Beneficiaries

—

Total drug cost

$28K

Distinct drugs

Brand share

24.2%

Top prescribed drugs

Latanoprost205 claims

Timolol Maleate69 claims

Moxifloxacin Hcl48 claims

Tobramycin/Dexamethasone38 claims

Prednisolone Acetate37 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

72.8

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Margerie Burness's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
SARASOTA COUNTY PUBLIC HOSPITAL DISTRICT	54	91
Surgery Center At University Park, Llc Ambulatory Surgical Center · Sarasota, FL	30	66
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	17	25
HCA HEALTH SERVICES OF FLORIDA, INC.	14	22
Krista Peverini Certified Registered Nurse Anesthetist (CRNA) · Sarasota, FL	12	20

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history